NEW YORK (GenomeWeb) – Arrayjet said today that it has secured an approximately $250,000 contract with the New York Bioscience Cluster for microarray instrumentation, printing, and expertise.

The Bronx-based NYBC provides gene expression research services for diseases and disorders related to immunology, cancer, diabetes, and liver function, and will use Arrayjet's Marathon Argus high-throughput bioprinter for much of this work, Edinburgh, Scotland-based Arrayjet said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.